Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1998 Nov;63(5):1352–1362. doi: 10.1086/302118

CTNS mutations in an American-based population of cystinosis patients.

V Shotelersuk 1, D Larson 1, Y Anikster 1, G McDowell 1, R Lemons 1, I Bernardini 1, J Guo 1, J Thoene 1, W A Gahl 1
PMCID: PMC1377545  PMID: 9792862

Abstract

Nephropathic cystinosis is an autosomal recessive lysosomal storage disease characterized by renal failure at 10 years of age and other systemic complications. The gene for cystinosis, CTNS, has 12 exons. Its 2.6-kb mRNA codes for a 367-amino-acid putative cystine transporter with seven transmembrane domains. Previously reported mutations include a 65-kb "European" deletion involving marker D17S829 and 11 small mutations. Mutation analysis of 108 American-based nephropathic cystinosis patients revealed that 48 patients (44%) were homozygous for the 65-kb deletion, 2 had a smaller major deletion, 11 were homozygous and 3 were heterozygous for 753G-->A (W138X), and 24 had 21 other mutations. In 20 patients (19%), no mutations were found. Of 82 alleles bearing the 65-kb deletion, 38 derived from Germany, 28 from the British Isles, and 4 from Iceland. Eighteen new mutations were identified, including the first reported missense mutations, two in-frame deletions, and mutations in patients of African American, Mexican, and Indian ancestry. CTNS mutations are spread throughout the leader sequence, transmembrane, and nontransmembrane regions. According to a cystinosis clinical severity score, homozygotes for the 65-kb deletion and for W138X have average disease, whereas mutations involving the first amino acids prior to transmembrane domains are associated with mild disease. By northern blot analysis, CTNS was not expressed in patients homozygous for the 65-kb deletion but was expressed in all 15 other patients tested. These data demonstrate the origins of CTNS mutations in America and provide a basis for possible molecular diagnosis in this population.

Full Text

The Full Text of this article is available as a PDF (904.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Charnas L. R., Bernardini I., Rader D., Hoeg J. M., Gahl W. A. Clinical and laboratory findings in the oculocerebrorenal syndrome of Lowe, with special reference to growth and renal function. N Engl J Med. 1991 May 9;324(19):1318–1325. doi: 10.1056/NEJM199105093241904. [DOI] [PubMed] [Google Scholar]
  2. Charnas L. R., Luciano C. A., Dalakas M., Gilliatt R. W., Bernardini I., Ishak K., Cwik V. A., Fraker D., Brushart T. A., Gahl W. A. Distal vacuolar myopathy in nephropathic cystinosis. Ann Neurol. 1994 Feb;35(2):181–188. doi: 10.1002/ana.410350209. [DOI] [PubMed] [Google Scholar]
  3. Ehrich J. H., Stoeppler L., Offner G., Brodehl J. Evidence for cerebral involvement in nephropathic cystinosis. Neuropadiatrie. 1979 May;10(2):128–137. doi: 10.1055/s-0028-1085319. [DOI] [PubMed] [Google Scholar]
  4. Fink J. K., Brouwers P., Barton N., Malekzadeh M. H., Sato S., Hill S., Cohen W. E., Fivush B., Gahl W. A. Neurologic complications in long-standing nephropathic cystinosis. Arch Neurol. 1989 May;46(5):543–548. doi: 10.1001/archneur.1989.00520410077027. [DOI] [PubMed] [Google Scholar]
  5. Fivush B., Green O. C., Porter C. C., Balfe J. W., O'Regan S., Gahl W. A. Pancreatic endocrine insufficiency in posttransplant cystinosis. Am J Dis Child. 1987 Oct;141(10):1087–1089. doi: 10.1001/archpedi.1987.04460100065027. [DOI] [PubMed] [Google Scholar]
  6. Gahl W. A., Bashan N., Tietze F., Bernardini I., Schulman J. D. Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis. Science. 1982 Sep 24;217(4566):1263–1265. doi: 10.1126/science.7112129. [DOI] [PubMed] [Google Scholar]
  7. Gahl W. A., Bashan N., Tietze F., Schulman J. D. Lysosomal cystine counter-transport in heterozygotes for cystinosis. Am J Hum Genet. 1984 Mar;36(2):277–282. [PMC free article] [PubMed] [Google Scholar]
  8. Gahl W. A., Charnas L., Markello T. C., Bernardini I., Ishak K. G., Dalakas M. C. Parenchymal organ cystine depletion with long-term cysteamine therapy. Biochem Med Metab Biol. 1992 Dec;48(3):275–285. doi: 10.1016/0885-4505(92)90074-9. [DOI] [PubMed] [Google Scholar]
  9. Gahl W. A. Cystinosis coming of age. Adv Pediatr. 1986;33:95–126. [PubMed] [Google Scholar]
  10. Gahl W. A., Reed G. F., Thoene J. G., Schulman J. D., Rizzo W. B., Jonas A. J., Denman D. W., Schlesselman J. J., Corden B. J., Schneider J. A. Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med. 1987 Apr 16;316(16):971–977. doi: 10.1056/NEJM198704163161602. [DOI] [PubMed] [Google Scholar]
  11. Gahl W. A., Tietze F., Bashan N., Bernardini I., Raiford D., Schulman J. D. Characteristics of cystine counter-transport in normal and cystinotic lysosome-rich leucocyte granular fractions. Biochem J. 1983 Nov 15;216(2):393–400. doi: 10.1042/bj2160393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gahl W. A., Tietze F., Bashan N., Steinherz R., Schulman J. D. Defective cystine exodus from isolated lysosome-rich fractions of cystinotic leucocytes. J Biol Chem. 1982 Aug 25;257(16):9570–9575. [PubMed] [Google Scholar]
  13. Gahl W. A., Tietze F., Butler J. D., Schulman J. D. Cysteamine depletes cystinotic leucocyte granular fractions of cystine by the mechanism of disulphide interchange. Biochem J. 1985 Jun 15;228(3):545–550. doi: 10.1042/bj2280545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Glusman G., Clifton S., Roe B., Lancet D. Sequence analysis in the olfactory receptor gene cluster on human chromosome 17: recombinatorial events affecting receptor diversity. Genomics. 1996 Oct 15;37(2):147–160. doi: 10.1006/geno.1996.0536. [DOI] [PubMed] [Google Scholar]
  15. Jean G., Fuchshuber A., Town M. M., Gribouval O., Schneider J. A., Broyer M., van't Hoff W., Niaudet P., Antignac C. High-resolution mapping of the gene for cystinosis, using combined biochemical and linkage analysis. Am J Hum Genet. 1996 Mar;58(3):535–543. [PMC free article] [PubMed] [Google Scholar]
  16. Jonas A. J., Smith M. L., Schneider J. A. ATP-dependent lysosomal cystine efflux is defective in cystinosis. J Biol Chem. 1982 Nov 25;257(22):13185–13188. [PubMed] [Google Scholar]
  17. Kaiser-Kupfer M. I., Caruso R. C., Minkler D. S., Gahl W. A. Long-term ocular manifestations in nephropathic cystinosis. Arch Ophthalmol. 1986 May;104(5):706–711. doi: 10.1001/archopht.1986.01050170096030. [DOI] [PubMed] [Google Scholar]
  18. Kimonis V. E., Troendle J., Rose S. R., Yang M. L., Markello T. C., Gahl W. A. Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis. J Clin Endocrinol Metab. 1995 Nov;80(11):3257–3261. doi: 10.1210/jcem.80.11.7593434. [DOI] [PubMed] [Google Scholar]
  19. Markello T. C., Bernardini I. M., Gahl W. A. Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med. 1993 Apr 22;328(16):1157–1162. doi: 10.1056/NEJM199304223281604. [DOI] [PubMed] [Google Scholar]
  20. McDowell G., Isogai T., Tanigami A., Hazelwood S., Ledbetter D., Polymeropoulos M. H., Lichter-Konecki U., Konecki D., Town M. M., Van't Hoff W. V. Fine mapping of the cystinosis gene using an integrated genetic and physical map of a region within human chromosome band 17p13. Biochem Mol Med. 1996 Aug;58(2):135–141. doi: 10.1006/bmme.1996.0041. [DOI] [PubMed] [Google Scholar]
  21. Oberfield S. E., Levine L. S., Wellner D., Novogroder M., Laino P., New M. I. Ascorbic acid treatment in nephropathic cystinosis in identical twins. Dev Pharmacol Ther. 1981;2(2):80–90. [PubMed] [Google Scholar]
  22. Oshima R. G., Pellett O. L., Robb J. A., Schneider J. A. Transformation of human cystinotic fibroblasts by SV40: characteristics of transformed cells with limited and unlimited growth potential. J Cell Physiol. 1977 Oct;93(1):129–136. doi: 10.1002/jcp.1040930116. [DOI] [PubMed] [Google Scholar]
  23. Peters U., Senger G., Rählmann M., Du Chesne I., Stec I., Köhler M. R., Weissenbach J., Leal S. M., Koch H. G., Deufel T. Nephropathic cystinosis (CTNS-LSB): construction of a YAC contig comprising the refined critical region on chromosome 17p13. Eur J Hum Genet. 1997 Jan-Feb;5(1):9–14. [PMC free article] [PubMed] [Google Scholar]
  24. Pisoni R. L., Thoene J. G., Christensen H. N. Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts. Role in therapeutic cystine removal? J Biol Chem. 1985 Apr 25;260(8):4791–4798. [PubMed] [Google Scholar]
  25. Reiter L. T., Murakami T., Koeuth T., Pentao L., Muzny D. M., Gibbs R. A., Lupski J. R. A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nat Genet. 1996 Mar;12(3):288–297. doi: 10.1038/ng0396-288. [DOI] [PubMed] [Google Scholar]
  26. Smith A. C., McGavran L., Robinson J., Waldstein G., Macfarlane J., Zonona J., Reiss J., Lahr M., Allen L., Magenis E. Interstitial deletion of (17)(p11.2p11.2) in nine patients. Am J Med Genet. 1986 Jul;24(3):393–414. doi: 10.1002/ajmg.1320240303. [DOI] [PubMed] [Google Scholar]
  27. Sonies B. C., Ekman E. F., Andersson H. C., Adamson M. D., Kaler S. G., Markello T. C., Gahl W. A. Swallowing dysfunction in nephropathic cystinosis. N Engl J Med. 1990 Aug 30;323(9):565–570. doi: 10.1056/NEJM199008303230903. [DOI] [PubMed] [Google Scholar]
  28. Steinherz R., Tietze F., Raiford D., Gahl W. A., Schulman J. D. Patterns of amino acid efflux from isolated normal and cystinotic human leucocyte lysosomes. J Biol Chem. 1982 Jun 10;257(11):6041–6049. [PubMed] [Google Scholar]
  29. Stratton R. F., Dobyns W. B., Airhart S. D., Ledbetter D. H. New chromosomal syndrome: Miller-Dieker syndrome and monosomy 17p13. Hum Genet. 1984;67(2):193–200. doi: 10.1007/BF00273000. [DOI] [PubMed] [Google Scholar]
  30. Thoene J. G., Oshima R. G., Crawhall J. C., Olson D. L., Schneider J. A. Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo. J Clin Invest. 1976 Jul;58(1):180–189. doi: 10.1172/JCI108448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Tietze F., Seppala R., Renlund M., Hopwood J. J., Harper G. S., Thomas G. H., Gahl W. A. Defective lysosomal egress of free sialic acid (N-acetylneuraminic acid) in fibroblasts of patients with infantile free sialic acid storage disease. J Biol Chem. 1989 Sep 15;264(26):15316–15322. [PubMed] [Google Scholar]
  32. Town M., Jean G., Cherqui S., Attard M., Forestier L., Whitmore S. A., Callen D. F., Gribouval O., Broyer M., Bates G. P. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet. 1998 Apr;18(4):319–324. doi: 10.1038/ng0498-319. [DOI] [PubMed] [Google Scholar]
  33. Vargas-Poussou R., Feldmann D., Vollmer M., Konrad M., Kelly L., van den Heuvel L. P., Tebourbi L., Brandis M., Karolyi L., Hebert S. C. Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome. Am J Hum Genet. 1998 Jun;62(6):1332–1340. doi: 10.1086/301872. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES